跳至主要内容
临床试验/NCT02573389
NCT02573389暂停3 期

A Pilot Study on the Effect of Transampullary Pancreatic Duct Stenting on Postoperative Pancreatic Fistula Rate After Distal Pancreatectomy

Kaiser Permanente0 个研究点目标入组 120 人开始时间: 2015年12月4日最近更新:
适应症

试验速览

阶段
3 期
状态
暂停
入组人数
120
主要终点
Post-operative pancreatic fistula

研究概览

简要总结

To determine whether pre-operative pancreatic stenting for distal pancreatectomy will impact the incidence of a post-operative pancreatic fistula, as defined by postoperative. If pre-operative pancreatic stenting appears to reduce the formation of Postoperative Pancreatic Fistula (POPF) in this pilot study, this will form the basis of a larger randomized trial in the future. The hypothesis is that pre-operative pancreatic duct stenting can significantly decrease the rate of development of a post-operative pancreatic fistula after distal pancreatectomy.

详细描述

Prophylactic pancreatic duct stenting is to be offered to all patients deemed a candidate for a distal pancreatectomy. This is a nonrandomized cohort study with a retrospective and prospective control group (Jan 2008 - Dec 2017 or sample size obtained) and a prospective endoscopic intervention group (September 2015 - Dec 2017 or until sample size obtained). We will then compare the rate of development of a postoperative pancreatic fistula between those patients who have preoperative stenting and those who do not. POPF will be defined as the amylase level of drain contents equaling three times or more the serum amylase on postoperative day 3, as defined by the International Study Group for Pancreatic Fistula (ISGPF) or an ICD-9 diagnosis of 577.8. The patient will have a pre-operative visit for stent placement and a post-operative visit for stent removal if still in place 4-6 weeks after distal pancreatectomy.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adult patients age 18 years of age and older
  • Patients undergoing distal pancreatectomy for primary pancreatic disorder or isolated metastases to the pancreas.

排除标准

  • Pediatric patients younger than age 18
  • Pregnant patients
  • Patients undergoing distal pancreatectomies performed en bloc for non- pancreatic pathologies (gastric cancer, renal cell cancer, etc).

结局指标

主要结局

Post-operative pancreatic fistula

时间窗: At 6 months when enrollment begins

Rate of post-operative pancreatic fistula will be evaluated at 6 months when enrollment begins. Early stop is determined under either of below conditions: * Effect size is smaller than needed to reach statistical difference even if number of enrollment is completed in one year. * Adverse events occurring from the pancreatic duct stenting itself, which include pseudocyst, delaying surgery, pancreatitis requiring prolonged hospital admission, or death. * There is statistical significant difference between control and intervention groups.

次要结局

  • Postoperative: Abscess, hemorrhage, reoperation, pulmonary embolism, mortality(3 days post surgery)
  • Pre-operative: Pancreatitis from pancreatic duct stent(1 - 2 weeks prior to distal pancreatectomy)

研究者

申办方类型
Other
责任方
Sponsor

相似试验